Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2011-4-4
pubmed:abstractText
AMPK has emerged as a critical mechanism for salutary effects of polyphenols on lipid metabolic disorders in type 1 and type 2 diabetes. Here we demonstrate that AMPK interacts with and directly phosphorylates sterol regulatory element binding proteins (SREBP-1c and -2). Ser372 phosphorylation of SREBP-1c by AMPK is necessary for inhibition of proteolytic processing and transcriptional activity of SREBP-1c in response to polyphenols and metformin. AMPK stimulates Ser372 phosphorylation, suppresses SREBP-1c cleavage and nuclear translocation, and represses SREBP-1c target gene expression in hepatocytes exposed to high glucose, leading to reduced lipogenesis and lipid accumulation. Hepatic activation of AMPK by the synthetic polyphenol S17834 protects against hepatic steatosis, hyperlipidemia, and accelerated atherosclerosis in diet-induced insulin-resistant LDL receptor-deficient mice in part through phosphorylation of SREBP-1c Ser372 and suppression of SREBP-1c- and -2-dependent lipogenesis. AMPK-dependent phosphorylation of SREBP may offer therapeutic strategies to combat insulin resistance, dyslipidemia, and atherosclerosis.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1932-7420
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
6
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
376-88
pubmed:dateRevised
2011-9-19
pubmed:meshHeading
pubmed-meshheading:21459323-AMP-Activated Protein Kinases, pubmed-meshheading:21459323-Animals, pubmed-meshheading:21459323-Atherosclerosis, pubmed-meshheading:21459323-Benzopyrans, pubmed-meshheading:21459323-Dietary Fats, pubmed-meshheading:21459323-Disease Models, Animal, pubmed-meshheading:21459323-Fatty Liver, pubmed-meshheading:21459323-Humans, pubmed-meshheading:21459323-Insulin Resistance, pubmed-meshheading:21459323-Lipogenesis, pubmed-meshheading:21459323-Male, pubmed-meshheading:21459323-Metformin, pubmed-meshheading:21459323-Mice, pubmed-meshheading:21459323-Phosphorylation, pubmed-meshheading:21459323-Receptors, LDL, pubmed-meshheading:21459323-Sterol Regulatory Element Binding Protein 1, pubmed-meshheading:21459323-Sterol Regulatory Element Binding Protein 2, pubmed-meshheading:21459323-Transcription, Genetic
pubmed:year
2011
pubmed:articleTitle
AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.
pubmed:affiliation
Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02481, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural